The following piece by blood donor Kathy Harris is something she voluntarily wrote following her very first blood donation. Please be sure to share it with your friends who are not yet blood donors as a bit of encouragement to...
By Julie Ruel, Social Media Manager, Stanford Blood Center Each morning, David Polnaszek gets up, changes into his Stanford Blood Center (SBC) hoodie, something he earned upon his tenth donation last year, and takes an hour-long walk around his neighborhood....
Tweet By Billie Rubin, Hemoglobin’s Catabolic Cousin, reporting from the labs of Stanford Blood Center Red Blood Cells (RBCs) have some particularly unusual characteristics for a cell. For one, they have a biconcave shape, giving both sides a “scooped-in” appearance....
Tweet By Erin Crager, Marketing Intern, Stanford Blood Center The purr of the Bloodmobile emits through crisp morning air. Parked just outside MIPS Technologies, its presence has become the norm here. Four times each year, blood drive coordinator Trish Leeper...
Tweet By Billie Rubin, Hemoglobin’s Catabolic Cousin, reporting from the labs of Stanford Blood Center Once upon a time (from early Greek and Roman physicians to the late 19th century), “blood-letting,” now known as phlebotomy, was a very popular practice...
By Julie Ruel, Social Media Manager, Stanford Blood Center Question: How might we increase the number of registered bone marrow donors to help save more lives? Katie Pfeiffer, Communications Director at the Haas Center for Public Service, recently invited me...
Tweet By Billie Rubin, Hemoglobin’s Catabolic Cousin, reporting from the labs of Stanford Blood Center Well, think of a little red blood cell (RBC) in 3D with lots of tiny little hairs sticking out of it. Type A people have...
By Erin Crager, Marketing Intern, Stanford Blood Center
The collateral damage associated with chemotherapy and radiation treatment may soon be a thing of the past. Medical students have traditionally been taught that the body's immune system generally doesn't turn on itself, even in the presence of a tumor. But Ed Engleman, MD and his research team at Stanford Blood Center have developed a method for training the body's immune system to do just that for prostate cancer. Their research over the past eighteen years has opened new doors for potentially curing other forms of cancer, as well.
Tweet By Julie Ruel, Social Media Manager, Stanford Blood Center Over the past five years, I’ve come to appreciate this time of year. Yes, wintertime at the office is very exciting around here! It’s the time of year when a...
We had the pleasure of working with the friendly folks at Micro-Documentaries on some short videos featuring a few very special blood recipients. Below is a piece written by Noah Stout from Micro-Docs about his experiences in filming the...